Gut Bacteria Imbalance Linked to Insulin Resistance

Specific imbalances in the gut microbiota are essential contributors to insulin resistance, a forerunner state of widespread disorders like type 2 diabetes, hypertension and atherosclerotic cardiovascular diseases, which are in epidemic growth, a new study has indicated. In the Danish study of 277 non-diabetic individuals and 75 type 2 diabetic patients, there was close collaboration [...]

By |2016-07-14T11:26:22+00:00July 14th, 2016|Uncategorized|0 Comments

Diabetes Sniffer Dogs Inspire New Treatment

A chemical found in our breath could provide a flag to warn of dangerously-low blood sugar levels in patients with type 1 diabetes, according to new research from the University of Cambridge. The finding, published in the journal Diabetes Care, could explain why some dogs can be trained to spot the warning signs in patients. [...]

By |2016-07-14T11:24:54+00:00July 14th, 2016|Uncategorized|0 Comments

Pioglitazone Decreases Diabetes Risk in Stroke Patients

Pioglitazone greatly decreases the risk of developing type 2 diabetes, especially for those who already have prediabetes and/or who have had strokes, according to a study presented at the American Diabetes Association's 76th Scientific Sessions at the Ernest N Morial Convention Centre in New Orleans. The Insulin Resistance Intervention after Stroke trial recently found that the thiazolidinedione [...]

By |2016-06-23T14:41:21+00:00June 24th, 2016|Uncategorized|0 Comments

New Link Between Diabetes and Alzheimer’s Disease

Drugs used to treat diabetes could also be used to treat Alzheimer’s disease, and vice versa, according to new research from the University of Aberdeen. This is the first study of its kind to show that Alzheimer’s disease can lead to diabetes, as opposed to diabetes occurring first as was previously thought. The study reports [...]

By |2016-06-23T14:39:44+00:00June 24th, 2016|Uncategorized|0 Comments

Existing Diabetes Drug Targets Liver Disease

Researchers have found that an existing diabetes drug can be used to halt progression of another disease that is a leading cause of liver transplants. A three-year clinical trial led by University of Florida Health Researcher Kenneth Cusi, MD, found that the drug pioglitazone is safe and effective in certain patients who have nonalcoholic steatohepatitis, [...]

By |2016-06-21T15:53:13+00:00June 22nd, 2016|Uncategorized|0 Comments

New Trial Aims to Prevent Type 1 Diabetes

A clinical study evaluating a new hypothesis that an inexpensive drug with a simple treatment regimen can prevent type 1 diabetes has been launched in Dundee. The autoimmune diabetes Accelerator Prevention Trial (adAPT) is led by Professor Terence Wilkin, of the University of Exeter Medical School, with support from colleagues at the University of Dundee and [...]

By |2016-04-20T12:00:36+00:00April 20th, 2016|Uncategorized|0 Comments

Dementia Mismanagement Costing Health System up to £1 Billion a Year

A new report by the International Longevity Centre – UK (ILC-UK) demonstrates that a failure to prevent, diagnose, and treat depression, diabetes and urinary tract infections in people with dementia could be costing the UK’s health and social care system up to nearly £1 billion per year. The report, Dementia and Comorbidities: Ensuring parity of [...]

By |2016-04-15T13:14:30+00:00April 15th, 2016|Uncategorized|0 Comments

Reduction in Emergency Admissions and Hospital Stays for Diabetes Patients

The number of people with diabetes admitted to hospital in an emergency has fallen by five per cent in the last five years, a new report indicates. The average length of stay in hospital for people with diabetes has also fallen, from nine days to 6.8 days over the same period. The All-Wales Diabetes Annual [...]

By |2016-03-30T15:27:51+00:00March 30th, 2016|Uncategorized|0 Comments

Health Charity Calls for Healthcare Professionals to Champion Local Change

A leading diabetes charity is looking for healthcare professionals in the Hywel Dda University Health Board to become Clinical Champions and give the leadership needed to improve services for people with diabetes in their area. The role is open to any healthcare professional experienced in treating the complex needs of people with diabetes and with [...]

By |2016-03-15T22:52:15+00:00March 15th, 2016|Uncategorized|0 Comments


The International Diabetes Federation (IDF) estimates that 371 million individuals are living with diabetes worldwide. This figure includes the 50 per cent whom, it is estimated, remain undiagnosed. There’s no doubt that the prevalence of diabetes is increasing across the world and it’s estimated that the figure will hit the half-billion mark by 2030. In [...]

By |2016-03-07T22:09:39+00:00March 7th, 2016|Uncategorized|0 Comments
Please Choose

Welcome to!
Are you a Qualified Healthcare Professional or Student?

Access to is solely restricted to qualified healthcare professionals and students within the sector.
Powered by Autience